IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 348 filers reported holding IONIS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $947,793 | -75.5% | 23,100 | -78.7% | 0.00% | -71.4% |
Q1 2023 | $3,868,784 | -0.1% | 108,248 | +5.6% | 0.01% | -12.5% |
Q4 2022 | $3,870,934 | +202.9% | 102,487 | +254.9% | 0.01% | +166.7% |
Q3 2022 | $1,278,000 | +53.4% | 28,880 | +28.4% | 0.00% | +200.0% |
Q2 2022 | $833,000 | -72.5% | 22,497 | -72.5% | 0.00% | -50.0% |
Q1 2022 | $3,031,000 | +21.7% | 81,830 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $2,491,000 | +276.9% | 81,830 | +315.2% | 0.00% | +100.0% |
Q3 2021 | $661,000 | -15.9% | 19,710 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $786,000 | -49.8% | 19,710 | -43.4% | 0.00% | -50.0% |
Q1 2021 | $1,566,000 | -20.5% | 34,844 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $1,971,000 | +698.0% | 34,844 | +731.2% | 0.00% | – |
Q2 2020 | $247,000 | +4.7% | 4,192 | -16.0% | 0.00% | – |
Q1 2020 | $236,000 | -35.9% | 4,992 | -18.1% | 0.00% | – |
Q4 2019 | $368,000 | -4.2% | 6,092 | -4.9% | 0.00% | – |
Q3 2019 | $384,000 | +1.9% | 6,407 | +9.3% | 0.00% | – |
Q2 2019 | $377,000 | -56.7% | 5,863 | -45.4% | 0.00% | -100.0% |
Q1 2019 | $871,000 | -70.4% | 10,733 | -80.6% | 0.00% | -66.7% |
Q4 2018 | $2,944,000 | -3.9% | 55,243 | -7.0% | 0.00% | 0.0% |
Q3 2018 | $3,063,000 | +23.8% | 59,380 | 0.0% | 0.00% | +50.0% |
Q2 2018 | $2,474,000 | -5.5% | 59,380 | 0.0% | 0.00% | -33.3% |
Q1 2018 | $2,618,000 | -24.4% | 59,380 | -13.8% | 0.00% | 0.0% |
Q4 2017 | $3,465,000 | – | 68,880 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tweedy, Browne Co LLC | 3,541,136 | $133,749 | 7.12% |
Bellevue Group AG | 9,743,900 | $368,027,103 | 4.88% |
M28 Capital Management LP | 126,300 | $4,770,351 | 4.55% |
Sicart Associates LLC | 246,258 | $9,301,165 | 3.28% |
Camber Capital Management LP | 1,925,000 | $72,707 | 2.49% |
Privium Fund Management B.V. | 148,807 | $5,557,941 | 2.11% |
Deep Track Capital, LP | 1,205,773 | $45,542,046 | 1.91% |
BVF INC/IL | 1,121,809 | $42,370,726 | 1.79% |
Orbimed Advisors | 1,993,600 | $75,298,272 | 1.44% |
Parkman Healthcare Partners LLC | 141,115 | $5,329,914 | 1.42% |